These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease. Aschan J, Ringdén O. Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365 [Abstract] [Full Text] [Related]
8. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia]. Chen HR, Ji SQ, Yan HM, Wang HX, Liu J, Xue M, Zhu L. Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394 [Abstract] [Full Text] [Related]
9. Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation. Weisdorf D, Filipovich A, McGlave P, Ramsay N, Kersey J, Miller W, Blazar B. Bone Marrow Transplant; 1993 Nov; 12(5):531-6. PubMed ID: 8298565 [Abstract] [Full Text] [Related]
12. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China. Liu QF, Xu XJ, Chen YK, Sun J, Zhang Y, Fan ZP, Xu D, Jiang QL, Wei YQ, Huang F, Feng R, Liu XL, Xu B, Meng FY. Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002 [Abstract] [Full Text] [Related]
18. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)]. Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L. Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179 [Abstract] [Full Text] [Related]
19. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L. Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268 [Abstract] [Full Text] [Related]
20. Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients. Blaise D, Olive D, Hirn M, Viens P, Lafage M, Attal M, Stoppa AM, Gabert J, Gastaut JA, Camerlo J. Bone Marrow Transplant; 1991 Aug; 8(2):105-11. PubMed ID: 1933050 [Abstract] [Full Text] [Related] Page: [Next] [New Search]